BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Eagle Pharmaceuticals Strengthens Management Team to Prepare for Future Growth

  Key additions deepen scientific, analytics and commercial expertise; positions Eagle to advance product pipeline and prepare for future commercial launches in oncology and critical care businesses

  November 2, 2020

   · 

  13 min read
• Biotech Bay

  ALX Oncology Announces November 2020 Virtual Investor Conference Participation

  ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, announced that Jaume Pons, Ph.D., Founder, President and Chief Executive Officer and other senior executives, will participate in two virtual investor conferences in November.

  November 2, 2020

   · 

  1 min read
• Business

  Recro to Report Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 9, 2020Conference Call and Webcast Scheduled for Monday, November 9, 2020 at 8:00 a.m. ET

  Recro Pharma, Inc. announced that it will report third quarter 2020 financial results on Monday, November 9, 2020.

  November 2, 2020

   · 

  1 min read
• Genetown

  Orchard Therapeutics to Host Virtual R&D Investor Event on Friday, November 13, 2020

  Orchard Therapeutics, a global gene therapy leader, announced that the company will webcast a virtual R&D event ‘New Horizons in Gene Therapy’ on Friday, November 13, 2020 from 9:00 a.m. to 11:00 a.m. ET.

  November 2, 2020

   · 

  3 min read
• Business

  Baudax Bio to Report Third Quarter 2020 Financial Results and Host Conference Call and Webcast on November 9, 2020

  Baudax Bio, Inc., a pharmaceutical company focused on therapeutics for acute care settings, announced that it will report third quarter 2020 financial results on Monday, November 9, 2020.

  November 2, 2020

   · 

  4 min read
• Business

  Apellis Pharmaceuticals Reports Third Quarter 2020 Financial Results

  Strategic collaboration announced with Sobi for global co-development and exclusive ex-U.S. commercialization rights for systemic pegcetacoplan

  November 2, 2020

   · 

  14 min read
• Business

  Fusion Pharmaceuticals Announces Collaboration with AstraZeneca to Develop and Commercialize Next-Generation Radiopharmaceuticals and Combination Therapies

  Collaboration Combines Fusion’s Targeted Alpha Therapies (TATs) Platform with AstraZeneca’s Antibody and Oncology Portfolio to Create Novel Cancer Therapies

  November 2, 2020

   · 

  7 min read
• Policy

  Janssen Submits Paliperidone Palmitate 6-Month (PP6M) Supplemental New Drug Application to U.S. FDA for Treatment of Schizophrenia in Adults

  If approved, PP6M will be the first and only long-acting injectable schizophrenia treatment with a twice-yearly dosing regimen

  November 2, 2020

   · 

  15 min read
• Drug Development

  Neuraly Receives FDA Clearance of Investigational New Drug Application to Initiate Phase 2B Trial of NLY01 for Patients with Alzheimer’s Disease

  Novel Mechanism of Action Inhibits Pathological Activation of Microglial Cells and Prevents Neuronal Cell Death

  November 2, 2020

   · 

  3 min read
• Business

  Seres Therapeutics to Host Third Quarter 2020 Financial Results and Operational Progress Conference Call and Webcast on November 9, 2020

  Seres Therapeutics, Inc. announced that management will host a conference call and live audio webcast on November 9, 2020 at 8:30 a.m. ET to discuss third quarter 2020 results and provide a general business update.

  November 2, 2020

   · 

  1 min read